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Background: To our knowledge, there has been no overall systematic review focusing on the methodological quality of full economic evaluation studies of self-management
interventions. Our objective was to systematically review the literature of full economic evaluation studies of self-management interventions in adult chronic patients and to
investigate their methodological quality and cost-effectiveness.
Methods: A data extraction form was developed to assess general and randomized controlled trial (RCT) -related characteristics, quality, of the RCTs, economic information and
quality of the economic evaluation studies by means of a quality assessment (CHEC-list for trial-based studies, adjusted CHEC-list for model-based studies).
Results: Twenty-three reports were found. Sixteen studies (73 percent) lack information on the control intervention(s). Only one study fulfilled all three criteria for quality of RCTs
and five studies (23 percent) did not meet any of these criteria. This review included one model-based study; the other studies were trial-based economic evaluation studies based on
a RCT. Eight studies (35 percent) used a societal perspective and 12 (60 percent) synthesized costs and effects. Seven studies were categorized into the highest category (<15
score), nine studies into the “moderate” group (9–14 score), six studies received a “low” score (<8) on the CHEC-list. Eighteen studies found the self-management
intervention(s) to be cost-effective compared with other interventions
Conclusions: Self-management interventions for adult chronic patients were heterogeneous and there was no clear, well-considered definition of self-management. Overall, the
methodological quality of the full economic evaluation studies was moderate and, therefore, cost-effectiveness results must be interpreted with caution. Future research will benefit
from further improvements in methodological quality of both economic study design and analysis, as well as a taxonomy for describing self-management interventions and their
contents.
Keywords: Systematic review, Economic evaluation, Self-management, Chronic health care
According to the World Health Organization (WHO), chronic
diseases are defined as diseases of long duration and generally
slow progression (1). Longer life expectancy and increasing
numbers of people living with chronic diseases go along with
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articles included for this review. M.v.E. wrote the initial draft of the manuscript. C.v.H., S.E., and
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the greater proportion of elderly people in Western society (2).
In parallel, healthcare costs are increasing inWestern countries.
The cost of chronic diseases and their risk factors are significant
and can rise to almost 7 percent of a country’s gross domestic
product (GDP) (3). Governments face the challenge to meet,
on the one hand, all of society’s healthcare related needs and
demands, and, on the other hand, the need to deal with scarce
financial andmaterial healthcare resources. The increased avail-
ability of new, often more expensive, healthcare interventions
for chronic patients makes it imperative for policy makers to
make a rational choice between alternatives.
Self-management is one of the healthcare interventions,
which has recently become more prominent and important in
chronic health care as it focuses on reaching optimization,
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Self-management interventions in chronic diseases
efficiency, and sustainability of care by managing the existing
intervention. In 1999, Lorig et al. (4) developed the Stanford
Chronic Disease Self-Management Program (CDSMP). The ef-
fectiveness of the CDSMP, based on Bandura’s Social Learning
Theory (5),was recently investigated in a systematic review con-
ducted by Franek (6). He found that, in comparison with care as
usual, CDSMP resulted in significant, short term improvements
in terms of health related quality of life and self-effectiveness.
The popularity of this particular intervention has risen over the
past two decades.
Defining self-management is a challenge, because a
wide variety of interpretations and explanations exist.
Self-management is often used interchangeably with self-care,
self-help, and education, among others. Barlow et al. (2) de-
fined self-management as: “An individual’s ability tomanage the
symptoms, treatment, physical, and psychosocial consequences
and lifestyle changes inherent in livingwith a chronic condition.
Efficacious self-management encompasses the ability to moni-
tor one’s condition and to affect the cognitive, behavioral, and
emotional responses necessary for maintaining a satisfactory
quality of life and, thus, establish a dynamic and continuous pro-
cess of self-regulation” (2). Because this definition adequately
captures the domain of self-management, we choose to use this
definition in this review and articles are selected in line with
this definition.
There are four reasons for doing this review. First, the sig-
nificance of self-management interventions (SMIs) in chronic
health care and pharmaceutical therapy has been acknowledged
(7;8). Second, previous research shows positive results regard-
ing the effectiveness of SMIs (9). Third, there is potential for
SMIs to be cost-effective for specific chronic diseases. However,
current evidence on the cost-effectiveness of SMIs is limited.
Fourth, following the previous arguments, this calls for new,
up-to-date evidence concerning the methodological quality of
these studies and the effect of this quality on the interpretation
of cost-effectiveness results.
To our knowledge, there has been no overall systematic re-
view focusing on the methodological quality of full economic
evaluation studies of SMIs. Therefore, our aim was to systemat-
ically review the literature of full economic evaluation studies,
both trial-based and model-based, of one or more SMIs in adult
chronic patients to investigate the methodological quality of the
studies and the cost-effectiveness of the interventions.
METHODS
Study Approach
This review is conducted according to the PRISMA guidelines,
containing twenty-seven items. This study was not registered
in the international prospective register of systematic reviews
(PROSPERO) before starting but we used a predefined research
protocol.
Selection Criteria
Full economic evaluation studies reporting on SMIs in line with
Barlow’s definition (2) of self-management were eligible for in-
clusion. A full economic evaluation is considered a comparative
analysis of two or more interventions in terms of both costs (re-
source use) and consequences (outcomes, effects) (10). It was
our goal to include asmany relevant papers as possible, however,
we focused on studies reporting a chronic disease. Studies were
excluded if patients could not be classified as having a chronic
disease or receiving chronic care, if participants were younger
than 18 years of age, if the study was not written in English
or Dutch and/or was published before 1990. A chronic patient
was defined as a person who experiences living with the afflic-
tion that often accompanies chronic disease (11). Furthermore,
we excluded studies when they did not report on original data
in a primary research paper (i.e., systematic reviews, congress
abstracts, and commentaries, among others).
Information Sources
Two electronic databases were searched for relevant articles
published between January 1990 and May 2014. Because the
majority of SMIs was developed and studied for their efficacy
in the past decade, we chose 1990 as the starting point for
our search. We used PUBMED and the National Institute for
Health Research Economic Evaluation Database (NHSEED).
Although NHSEED makes an extensive search of PUBMED
among others (CINAHL, Embase, PsycINFO, and MEDLINE)
on a weekly basis, using a very efficient filter embedded in their
search engine for economic evaluation studies, we performed
a separate search in PUBMED as well as this combination is
regarded as the most valid search strategy for economic evalu-
ation studies (12;13). In addition, reference lists were screened
for additional relevant publications.
Search Strategy
The search string used in this studywas based on leading reviews
of self-management and existing economic evaluation search
strategies (2;12–16). The following set of keywords was used
to search PUBMED, either as a MeSH term if possible, or as
general search term title/abstract: [“self management”], [“self-
management”], [“self care”], [“self-care”]; and [“economics”],
[“cost analysis”], [“cost benefit analysis”], [“cost-benefit anal-
ysis”], [“cost effective”], [“cost-effective”]. Because NHSEED
searches only databases for economic evaluation studies, only
the set of keywords for self-management was used to identify
relevant studies in this database.We used a “language” filter (ei-
ther Dutch or English) and searched only for articles published
in or after 1990. All results were downloaded into the biblio-
graphic management software EndNoteX and duplicates were
removed. A detailed search string is presented in Supplementary
Figure 1.
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Figure 1. Flowchart of study selection.
Study Selection
Eligibility assessment was performed by the primary researcher
(M.v.E.) and three other reviewers (C.v.H., S.E., and G.v.M.).
M.v.E. did the electronic database search and screened all ar-
ticles on title and abstract. All papers that met the eligibility
criteria were categorized in the group as “potential,” and papers
that undoubtedly did not meet these criteria were immediately
excluded. In case of doubt, decisions were made through con-
sensus by two of the four reviewers (M.v.E. with C.v.H., and
G.v.M. with S.E.). Subsequently, all articles meeting the eligi-
bility criteria were assessed independently by two of the four
reviewers. This assessment consisted of data extraction of all
selected full-text articles in addition with a critical appraisal
of the Consensus Health Economic Criteria List (CHEC-list).
Any disagreement on data extraction between reviewers was
resolved through consensus.
Data Extraction and Methodological Quality Assessment
By means of a predefined form (17), the following data were
extracted from the papers: First, general and randomized con-
trolled trial (RCT) information was retrieved. Quality of RCTs
was determined through assessment: the use of intention-to-
treat analysis (ITT) (yes, no, unclear), allocation concealment
(adequate, unclear), and blinding of outcome assessors (ade-
quate, unclear) (18). If the paper reporting on the economic
evaluation study did not contain sufficient information on trial
design, the paper describing the original study design was used
for data extraction. Second, economic informationwas assessed,
including the economic evaluation design used, synthesis of
costs and effects, and cost-effectiveness of the SMI (yes/no).
The quality of the economic evaluation was determined by
means of the adjusted CHEC-list which is fit for RCTs and
model-based studies (19) consisting of nineteen yes-or-no ques-
tions (20). The CHEC-list is recommended by Cochrane (18).
Because no weighting exists for the CHEC-list, we used scores
of 1 (yes) and 0 (no) to value the items and categorized stud-
ies as: low (<8 score), moderate (9–14 score) and high (>15
score). For studies that did not discount costs and/or effects due
to a 12-month or less follow-up, item 14 (were future costs and
outcomes discounted) on the CHEC-list was disregarded and for
these studies a maximum score of eighteen could be obtained.
However, this had no impact on the categorization of studies.
RESULTS
Review Profile
A total of 2,760 records were identified from the search
(Figure 1). After removing duplicates (n = 248), 2,512 records
were screened on title and abstract; of these, 2,454 records were
excluded. The main reasons for exclusion were: not reporting
data in a primary research paper, using a description of self-
management not in line with the Barlow’s definition and the
absence of cost data. A total of fifty-eight full text records were
then assessed by the reviewers, of which twenty-three fulfilled
the inclusion criteria (21–43). One study performed by Kaup-
pinen et al. was published as an additional publication (29) with
respect to a previous study (28). The data of this publication
were also extracted and presented in this review, but for simpli-
fication purposes only the reference of the original article (28)
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will be used in the text. Accordingly, the results are based on
twenty-three publications from twenty-two studies.
General, RCT-Related and Economic Characteristics
All twenty-two studies were published after 1998 (Table 1, Sup-
plementary Tables 1 and 2), eight were based in the United
Kingdom (24;27;30;31;34;36;38;40), six in mainland Europe:
the Netherlands (33;35), Finland (28), Sweden (22), Norway
(23), Spain (26), six in the United States (US) (25;37;39;41–
43) and two in Canada (21;32). Asthma/chronic obstructive
pulmonary disease (COPD) and diabetes were the most com-
mon disease categories in eleven studies. One study used data
from an RCT to construct a Markov model. All others used an
RCT design including two, three, or four intervention groups.
A total of 23 percent (n = 5) of the studies evaluated two or
more SMIs.
The intensity of the SMI varied between studies, from two
visits and a phone call up to sixty computer sessions per par-
ticipant. The SMI was primarily delivered by a (trained) nurse
in eleven studies. Almost one-third (n = 8) of the interventions
were offered to patients at home. In three studies, interventions
took place in the hospital, in three studies interventions were
at a special clinic and in three other studies interventions were
at the general practitioner’s (GP) office. All SMIs consisted of
multiple sessions (individual or group), sometimes combined
with phone calls. Sixteen studies (73 percent) provided lim-
ited or missing information on the description of the control
intervention(s), the other 27 percent of the studies were thor-
ough in reporting on the control intervention(s). Only one study
had a 10-week follow-up period. A 12-month follow-up period
was chosen in fifteen studies, and the other seven studies had
follow-up periods ranging from 18 months up to 10 years.
In seven studies (32 percent), ITT analyses were performed;
in other words, all randomized patients were analyzed in the as-
signed group regardless of whether they completed the follow-
up period or received the treatment (ITT). The remaining 15
studies either did not us an ITT analysis method (n= 8) or it was
unclear whether an ITT analysis was conducted (n= 7). Twelve
studies (n = 12) reported adequately concerning the conceal-
ment of allocation. Limited to no information on concealment
of allocation was provided in the remaining ten studies. Only
four studies (18 percent) reported blinding of the outcome as-
sessor(s). The remaining eighteen studies either mentioned that
a nonblinded study was concerned, or insufficient information
was provided on blinding.
In 68 percent (n = 15) of the studies, a perspective of anal-
ysis was mentioned and almost half of these (n = 8) performed
their analyses from a societal perspective. In 32 percent of the
studies (n = 7), no information was provided on the chosen
perspective. All but four of the studies performed either a cost-
effectiveness analysis (CEA) or cost utility analysis (CUA),
although it is worth mentioning that authors used both concepts
interchangeably. The four other studies conducted either a cost
analysis or cost-minimization analysis (CMA). Two studies did
not measure any type of healthcare costs (categorized as hospi-
tal visits, GP visits, and other healthcare consumption, among
others).
Patient and family costs (categorized as costs of informal
care and travel costs, among others) were not identified in ten
studies. In eleven studies, no costs outside the healthcare sector
(categorized as productivity costs, among others) were identi-
fied. One study took intervention costs into account. All but
three of the studies used a cost questionnaire, medical/hospital
records, or both, among other instruments as means for mea-
suring costs. Approximately 55 percent of the studies (n = 12)
based their cost valuation on either cost price estimations, cost
guidelines, or both. The remaining 45 percent of the studies (n
= 10) used either tariffs, tariffs combined with cost guidelines,
cost price estimations combined with the human capital ap-
proach, tariffs combined with nurse wages, or did not mention
any form of cost valuation. Almost half of the studies (n = 10)
did not mention a price year with respect to the cost calculation.
Four of eight studies with a follow-up period of 18 months or
more did not report a discount rate.
Ten studies used only generic effect measures, four used
only disease specific effect measures and eight used both. In
seven studies, uncertaintywas handled using test variable uncer-
tainty methods (e.g., sensitivity analysis), five studies used test
sample uncertainty methods (e.g., bootstrapping) and in three
studies a combination of these was used. Other methods of han-
dling uncertainty were probabilistic analysis and test sample un-
certainty combined with complete case analysis. In five studies,
no handling of uncertainty was mentioned. Thirteen studies (59
percent) used an incremental cost-effectiveness ratio (ICER) to
synthesize costs and effects, and one study combined the ICER
with the calculation of a Net Monetary Benefit (NMB). The
remaining nine studies did not mention any method for synthe-
sizing costs and effects. Almost half of the studies (n = 10)
made cost-effectiveness results visible. Seven studies presented
a cost-effectiveness acceptability curve (CEAC), the remaining
three used either a cost-effectiveness plane (CE plane), a CEAC
and CE plane combined, or a cost-concentration curve.
Quality of the Economic Evaluation
A total of fourteen studies could obtain a maximum of 18 points
on theCHEC-list (Table 2); the other eight could obtain nineteen
points. Seven studies were categorized into the highest category
(>15 score (25;30;31;33;35;36;38), nine studies into the group
“moderate” (9–14 score) (22–24;27;28;37;39;42;43), and six
studies received a “low” score (<8) (21;26;32;34;40;41). On
average, all studies included in this review scored 13.9 on the
CHEC-list range 4–17. Studies published before 2007 (n = 10)
had on average a lower score in comparisonwith the studies pub-
lished in 2008 or later (n = 12). There were several CHEC-list
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Table 1. General, RCT-Related and Economic Characteristics
Self-management Outcome Cost SMI cost-
Diseasea Author N Interventions Comparator(s) measure(s) Perspectiveb measurement effective
Asthma Gallefos23
(2001)
78 SMIc with group/individual sessions provided by a
trained nurse of physiotherapist, following an
individual SM plan
- Usual care - QoLd
- Costs
- Forced expiratory
volume
- Society - Medical
records
- Registrations
Yes
Kauppinen28
(1998)
162 SM plan to manage individual asthma peak-flow
meters and record values in a special diary
- Educational
program
- QoL
- Costs
- Forced expiratory
volume
NI - Medical
records
Yes
McLean32
(2003)
242 Enhanced pharmaceutical care including teach of
self-management according to the HOP Asthma
Care Module
- Usual care - QoL
- Costs
- Peak flow
NI - Medical
records
Yes
Van der
Meer33
(2010)
200 Internet based SMI including online/group-based
education according to a computerized personal
action plan
- Usual care - QoL
- Costs
- Society - CQe Yes
Schermer41
(2002)
192 Guided SMI with education and training of skills
provided by a family physician
- Usual care - QoL
- Costs
- Society - CQ
- Diary
Yes
Diabetes Gillet24
(2010)
122 Diabetes group education and SM program
(DESMOND) focusing on lifestyle factors and
cardiovascular risk factors
- Usual care - QoL
- Costs
- Society - CQ
- Medical
records
Yes
Handley25
(2008)
226 Automated telephoned SMI providing surveillance
and education including nurse care management
and one-on-one telephone counselling
- Usual care - QoL
- Costs
- Health
systems
- Intervention
costs
Yes
Jansa26
(2006)
40 Telecare SMI focusing on informed decision making
about daily diabetes self-management
- Usual care - QoL
- Costs
- Metabolic control
NI - CQ Yes
Ritzwoller39
(2011)
280 Viva Bien SMI based on social-cognitive,
social-ecologic, and problem-solving factors to
improve risk factors known to affect coronary
heart disease
- Usual care - QoL
- Costs
- Clients and
health plan
- CQ
- Intervention
logs
Yes
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Table 1. Continued
Self-management Outcome Cost SMI cost-
Diseasea Author N Interventions Comparator(s) measure(s) Perspectiveb measurement effective
Cardiovascular
disease
Cline22
(1998)
199 SM education program including guidelines for
self-management of diuretics and providing
information and individual guidelines
- Usual care - Hospitalization
- Re-admission time
- Costs
NI - Hospital
records
Yes
Jowett27
(2006)
617 SM anticoagulation program providing training and
self-management tools to manage individual
anticoagulation
- Usual care - QoL
- Costs
- Society - CQ
- Medical
records
No
Reed37
(2010)
636 Tailored SMI incorporating behavioral and
educational aspects of treatment adherence
- Blood pressure
monitoring
- Usual care
- Patient time
- Costs
- Society - CQ
- Telephone
calls
Yes
Bourbeau21
(2006)
191 SMI on education including teaching at home and
telephone calls by a case manager
- Usual care - Hospitalization
- Costs
- Healthcare
payer
- Interviews
- Hospital
records
Yes
Khdour30
(2011)
127 Pharmacy-led SMI education program to increase
patients’ self-efficacy and manage breathing
difficulties
- Usual care - QoL
- Costs
- NHS
- Personal
social service
- CQ
- Medical
records
Yes
Neurological
problems
Latimer31
(2013)
34 Self-managed computer therapy with speech and
language therapy provided by a volunteer
- Usual care - QoL
- Costs
- Healthcare
sector
- Personal
social service
- Patient and
carer diaries
Yes
Moss-
Morris34
(2012)
45 Internet-based cognitive behavioral SMI including
computer sessions and telephone calls
- Usual care - Fatigue
- QoL
- Costs
NI - CQ Yes
21
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Table 1. Continued
Self-management Outcome Cost SMI cost-
Diseasea Author N Interventions Comparator(s) measure(s) Perspectiveb measurement effective
Other Van Os-
Medendorp35
(2012)
199 Individualized e-health SMI incorporating
self-management training and internet-guided
monitoring, using an internet portal
- Usual care - Atopic dermatitis
severity
- QoL
- Costs
- Society - CQ
- Records
- Diaries
Yes
Patel36
(2009)
812 SM program plus education booklet (Challenging
Arthritis) designed to improve self-efficacy,
based on social cognitive theories
- Education - QoL
-Costs
- Society - CQ
- Client service
receipt
No
Richardson38
(2013)
296 Pragmatic rehabilitation self-management
program: an individualized program of activity
and improved sleep
- Supportive
listening
- Usual care
- QoL
- Costs
- NHSf
- Social
service
perspec-
tive
- CQ No
Robinson40
(2005)
420 Self-help group meetings to share experiences of
living with functional bowel symptoms and
providing approaches to help manage symptoms
- Guidebook - Consultations
- Costs
NI - CQ
- Primary care
records
Yes
Strong42
(2006)
371 Psychology-led and lay-led self-care intervention to
provide tools to reduce back pain-related activity
limitations
- Education
- Usual care
- QoL
- Costs
NI - Databases Yes
Wang43
(2012)
591 Telephone-based SMI providing individual training
and a blood-pressure device, in combination with
behavioral treatment
- Medication
management
- Usual care
- Blood pressure
- QoL
- Costs
- Healthcare
sector
- Hospital
records
No
aDisease categories are further explained in Supplementary Table 1.
bNI, no, or limited, information available.
cSMI, self-management intervention.
dQoL, quality of life.
eCQ, cost questionnaire.
fNHS, National Health Service.
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Table 2. Critical Appraisal of the Quality of the Economic Evaluation (+ = the Article Sufficiently Handled the CHEC-List Criterion)
Effects Conclusions No
Study Alter- Appr. Costs in Costs in Effects Incre- follow conflict
population natives Research Appr. Time Persp- Relevant physical valued Relevant physical valued mental Dis- Sensitivity data Genera- of Ethical
described described question design horizon ective costs units appr. effects units appr. analysis counting Analysis reported lizability interest issues
Gallefos23 + + + + + + + + + + + + ∗ + + +
Kauppinen28 + + + + + + + + + +
McLean32 + + + ∗ +
Van der Meer33 + + + + + + + + + + + + ∗ + + + +
Schermer41 + + + + + + + +
Gillet24 + + + + + + + + + + + + + +
Handley25 + + + + + + + + + + + + ∗ + + + + +
Jansa26 + + + + + ∗
Ritzwoller39 + + + + + + + + ∗ + + + + +
Cline22 + + + + + + + + + + ∗ + + + + +
Jowett27 + + + + + + + + + + ∗ + + +
Reed37 + + + + + + + + +
Bourbeau21 + + + + ∗ + + +
Khdour30 + + + + + + + + + + + ∗ + + + +
Latimer31 + + + + + + + + + + + + + + + +
Moss-Morris34 + + + + + + + ∗ +
Van Os-Medendorp35 + + + + + + + + + + + + + + +
Patel36 + + + + + + + + + + + + + ∗ + + + +
Richardson38 + + + + + + + + + + + + + + + + +
Robinson40 + + + ∗ +
Strong42 + + + + + + ∗ + + +
Wang43 + + + + + + + + + + + + +
∗Discounting not necessary due to follow-up up to 12 months.
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items onwhich various studies did not score points. For instance,
twelve studies did not justify their choice of perspective. Half
of the studies (n = 11) did not give a full identification of all
relevant costs in relation to the perspective. Twelve studies did
not give a detailed description of the competing interventions
and ten studies did not perform a sensitivity analysis. Thirteen
studies reported no ethical aspects and did not elaborate on the
characteristics of the population experiencing the disease and
intervention and how this may have distributional implications.
Cost-Effectiveness
In eighteen studies (82 percent), the authors found the SMI to be
cost-effective (Table 3), either due to increased costs and effects
in comparison with the control intervention (24;25;33;37;42),
or decreased costs and increased effects in comparison with the
control intervention (21–23;26;28;30–32;34;35;39–41). One of
the twenty-two studies did not find positive cost-effectiveness
results at the 12 months follow-up, but in the additional publi-
cation focusing on long term cost-effectiveness the SMI proved
cost-effective. Four studies concluded that the SMIwas not cost-
effective; three found no significant differences in comparison
with the control intervention and in one study the control inter-
ventionwas cheaper andmore effective and, therefore, dominant
over the SMI.
DISCUSSION
As far aswe know, this is the first overall systematic reviewof the
methodological quality and cost effectiveness of full economic
evaluation studies of SMIs in adult chronic patients. Twenty-
two studies of twenty-three publications were identified, in most
cases published either in Europe or theUnited States. All studies
were published from 1998 onward and more than half of the
studies were published after 2006. This review included one
model-based and 21 trial-based economic evaluations. Most of
the studies performed either a cost-effectiveness analysis or a
cost-utility analysis.
The reported SMIs were very heterogeneous in terms of
time span, intensity, contents, interventions providers, and target
populations. In general, the methodological quality was mod-
erate, despite the fact that the majority of studies were RCTs.
Nevertheless, only one study fulfilled all three evaluated quality
criteria (ITT, allocation concealment, and blinding of outcome
assessor), and in five studies, none of these criteria were met.
Furthermore, there was lack of detailed information on the con-
trol intervention(s) among all studies and in some cases nothing
was reported.
Only seven of the twenty-two studies that reported data on
costs had an acceptable score on the CHEC-list and the majority
of studies had either a moderate or low score. The methodolog-
ical quality of the economic evaluation was very mixed, but this
was insufficient in a greater part of the studies, which were un-
clear on synthesizing costs and effects and sensitivity analyses.
Eleven studies did not report on the perspective of analysis but
the majority of those who did used a societal perspective. How-
ever, the majority of studies with high methodological quality
did show positive cost-effectiveness results of the SMIs. Also,
these high quality studies were more likely to report a QALY as
outcome measure compared with studies with moderate or even
low methodological quality. Studies with higher methodolog-
ical quality reported extensively on methods of analysis, and
provided arguments for choices and considerations with regard
to cost-analyses. We found that more recently published stud-
ies showed higher methodological quality. This might also be
due to the fact that the economic evaluations were conducted as
independent study and not integrated with the effect study.
We encountered several difficulties in selecting of studies
reporting SMIs and in the categorization of these interventions.
It was evident in advance that the absence of a clear and solid
definition would pose difficulties. We chose a definition for-
mulated by Barlow et al. (2) that in our view captured the full
domain of self-management adequately and we used this defi-
nition as indicator for the selection of relevant articles for this
review. Despite choosing this definition we found it a major
challenge to use the definition in our research. This can be il-
lustrated by the rejection of an article with self-management
in its title as we found that the contents of the article and the
description of self-management did not fit our definition (44).
Another difficulty was in categorizing SMIs. Self-
management can serve as an intervention on its own with,
for example, educational sessions and self-help activities as
sub-elements, or self-management can be a sub-element of an
educational intervention. Furthermore, self-management, ed-
ucation, self-care, and self-help are continuously being used
interchangeably, sometimes even for the same activities or pro-
grams in one study. A review conducted by Nolte and Osborne
(45) on the outcomes of chronic disease self-management in-
terventions found that due to the different types of SMIs it is
very difficult to estimate the true impact of these interventions.
These findings are indicative of the highly ambiguous and com-
plex character of an intervention becoming vastly more popular
among scientists and healthcare providers and the difficulties,
which researchers encounter when reviewing the literature on
this topic.
The majority of studies (n = 18) found the SMI(s) to be
cost-effective in comparisonwith other, mostly care as usual, in-
terventions. SMIs are usually multi-faceted programs in which
different strategies and techniques are used and applied to help
patients to manage their disease over time. Furthermore, SMIs
tend to increase understanding and awareness among patients
considering their own disease. This allows them to, for exam-
ple, get a better idea of which healthcare services are necessary
to cope with their current situation and may improve medicine
adherence. This could easily result in a decrease of healthcare
consumption and, therefore, a decrease in costs; hence, it seems
plausible for self-management interventions to prove to be
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Table 3. Cost-Effectiveness Results
Disease Author Main outcomea ICERa
Asthma Gallefos23 (2001) - Cost savings of 3400 NOK and 4500
- NOK per patient
- 10-unit improvement SGRQ
- 5% REV
- -3,400 NOK per 10 point improvement on SGRQ
- -4,500 NOK per 5% improvement in FEV
Kauppinen28 (1998) - SMI is more costly than the control intervention at
12 months
- Dominant control intervention at 12 months
- Negative net benefit at 12 months
- 364 less sickness days for patients in self-
management group at 5 years
- No significant differences between groups in
clinical and health-related outcomes at 5 years
- 203 FIM (15D)
- 162 FIM (SGRQ)
- 140 FIM (FVC)
- 86 FIM (FEV)
- 1,845 FIM (PD)
- 110 FIM (PEF)
McLean32 (2003) - Cost savings of 201 USD per patient
- Symptom scores decreased by 50%
- PEF readings increased by 11%
- Reduction in days off work
- Reduction of inhaled beta-agonists by 50%
- Overall quality of life improved by 19%
- Emergency room visits and medical visits
decreased by 75%
NI
Van der Meer33
(2010)
- Cost increase of 641 USD per patient
- QALY gain of 0.024 per patient
- 26,700 USD per QALY gained
Schermer41 (2002) - Cost savings of 13 Euro per patient
- QALY gain of 0.039 per patient
- 33 Euro per successfully treated/week
Diabetes Gillet24 (2010) - Cost increase of 209 GBP (trial based costs) and 82 GBP
(’real life’ costs) per patient
- QALY gain of 0.0392 per patient
- 5,387 GBP per QALY (trial based)
- 2,092 GBP per QALY (’real life’ costs)
Handley25 (2008) - Cost increase of 782 USD per patient
- QALY gain of 0.012 per patient
- 65,167 USD per QALY gained
Jansa26 (2006) - Cost savings of 275 USD per patient
- No differences in HbA1c
- 9% less patients with hypoglycemic events
- Points improvement DQOL
- Point decrease SF-12
- Point decrease diabetes knowledge test
- 12% less patients with glycemic controls
NI
Ritzwoller39 (2011) - Self-management: 4,634 USD total costs per patient
and 7,723 USD marginal costs
NI
Cardiovascular
disease
Cline22 (1998) - Cost saving of 1,300 USD per patient
- One year survival rate 1.8% higher for SMI
NI
Jowett27 (2006) - Cost increase of 295 GBP per patient
- No significant differences in QALYs
- 31,437 GBP per QALY gained
Reed37 (2010) - Cost increase of 297 USD per patient
- Improvement of blood pressure control of 11%
- Other outcomes no significant differences
- 11,570 USD per life-year saved
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Table 3. Continued
Disease Author Main outcomea ICERa
COPD Bourbeau21 (2006) - Cost savings of 2,149 USD per patient
- Reduced hospital admissions 39.8%
- Reduced emergency department visits 41%
- Reduced unscheduled physician visits 58.9%
- 4,214 USD (n=14), 2,053 USD (n=30),
1,326 USD (n=50) and 1,016 USD (n=70)
per hospitalisation prevented
Khdour30 (2011) - Cost savings of 672 GBP per patient
- QALY gain of 0.065 per patient
- 3,278 GBP per QALY gained
Neurological
problems
Latimer31 (2013) - SMI: 19,124 GBP and 3.22 QALY gain per person
- Usual care: 19,687 GBP and 3.07 QALY gain per person
- Incremental costs and incremental QALY: 437 GBP and 0.14
- 3,058 GBP per QALY gained
Moss-Morris34
(2012)
- SMI: 211 GBP mean costs and 0.12 QALY gain
- Usual care: 214 GBP mean costs and 0.12 QALY gain
- Due to higher baseline QALY for intervention group,
QALY gain for intervention group was higher
NI
Other Van Os-Medendorp35
(2012)
- E-health self-management training would save 594 USD per
patient in the first year after treatment
- E-health is 73% likely to be cost-effective
NI
Patel36 (2009) - Cost increase of 101 GBP per patient
- No significant differences in QALYs between interventions
- 279 GBP per QALY gained (SF-36 mental health
component)
- 1,189 GBP per QALY gained (SF-36 physical
health component)
- 13,473 GBP per QALY gained (VAS)
Richardson38 (2013) - SMI: +218 GBP and -.012 QALY vs. care as usual
- Supportive listening: +460 GBP and -.042 QALY vs care as
usual
- Care as usual is dominant vs. both treatments,
65% likelihood of being cost effective
NI
Robinson40 (2005) - Cost savings of 73 GBP (or 40%)
- Primary care consultations reduced with 60%
NI
Strong42 (2006) - Cost increase of 168 USD and 172 USD
- Low-impact back pain days increase with 6 and 24
- 9.70 USD per low back-pain day (lay intervention)
- 6.13 USD per low back-pain day
(psychologist intervention)
Wang43 (2012) - No significant changes in costs and effects after
18 months follow-up
NI
aICER, incremental cost-effectiveness ratio; OK, Norwegian Krone; SGRQ, St. George’s Respiratory Questionnaire; REV, forced respiratory volume; SMI, self-management intervention;
FIM, Finnish Markka; 15D, Health State Descriptive System Questionnaire; FVC, forced vital captivity; PD, airway hyper responsiveness; PEF, peak expiratory flow; QALY,
quality-adjusted life year; SF-36, short-form 36.
cost-effective. However, the cost-effectiveness results of the
studies included in this review must be interpreted with cau-
tion because thirteen studies with a moderate or low quality
score conclude that the SMI is cost-effective. It is imperative
that these conclusions are preceded by a solid methodological
study quality on the one hand and a clear and explicit under-
standing of the theoretical context of the SMI on the other hand.
In this review, we explored the methodological quality
of economic evaluation studies of SMIs in adult chronic pa-
tients, and investigated their cost-effectiveness. Our findings
were in line with conclusions from previous related research.
Willems et al. (9) conducted a review on the cost-effectiveness
of SMIs in asthma and concluded that due to wide diversity
in interventions and poor methodological quality, conclusions
had to be interpreted with caution. Dorn (46) concluded that
self-management has the potential to improve outcomes for
chronic patients; however, the quality of studies was subpar due
to the challenge of defining self-management and developing
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practical self-management interventions. In addition to previ-
ous findings, we find it remarkable that the increased popularity
of SMIs has not been accompanied by the development of a
clear, well-considered definition of the concept.
Limitations of This Review
First, the difficulties we encountered with the concept of
self-management can be considered a limitation, as already
mentioned in previous parts of the discussion. However, we
chose a well-known definition of self-management after review-
ing relevant literature, and two independent assessors decided
whether the SMI was in line with our chosen definition of self-
management. Second, we did not register this systematic review
at PROSPERO but we did use a predefined research protocol.
Third, we chose 1990 as the starting year for our search strat-
egy, so we may have missed relevant articles published before
this year. However, because the domain of both economic eval-
uation and self-management have been subject to scientific re-
search mainly only for the past two decades (only two studies
included in this review were published before 2000), we do
not expect to have missed many relevant publications. Fourth,
we used only two databases for our search strategy. Because
NHSEED systematically searches multiple databases, all 23
studies included in this review can be found in both PUBMED
and NHSEED, and a reference check of all included studies did
not result in additional relevant studies we can argue that these
two databases suffice for this review. Fifth, conference abstracts
were excluded; hence, we could have missed some important
on-going studies. However, because it would not be possible
to analyze these data with the chosen research method we de-
cided to exclude them. Finally, the use of the adjusted version of
the CHEC-list may count as a limitation. The questions for the
model-based studies were not valued by a Delphi panel yet (19).
However, as only one of the included studies in our reviewwas a
model-based economic evaluation this will not have influenced
our study findings.
CONCLUSION
From this systematic review, we can conclude that the SMIs
of adult chronic patients reported were heterogeneous and no
clear, well-considered definition of self-management was used.
Furthermore, the number of economic evaluation studies of
SMIs is increasing, as is methodological quality. However, in
general themethodological quality of the assessed full economic
evaluation studies was moderate, the cost-effectiveness results
must, therefore, be interpreted with caution.
RECOMMENDATIONS
For future research, we recommend that the methodological
quality of economic evaluation studies of SMIs must be im-
proved. One of the major difficulties we encountered was with
the taxonomy of self-management and SMIs. We strongly rec-
ommend that future research efforts focus on defining the con-
cept of self-management in such a way that it diminishes the
fogginess around this concept. Not only researchers, but also
healthcare decision makers, professionals and patients will ben-
efit of this. Other difficulties related to the methodological qual-
ity of the economic evaluation studies. Up to date methods
must be used for conducting economic evaluations such as the
CHEERS guidelines (47). Furthermore, more effort must be put
in improving trial design and reporting.Wewould advise that fu-
ture research uses the adjusted CHEC-list (19) to assess model-
based studies and to develop for CHEC-list items. In addition,
we found a very limited number of economic evaluation studies
in comparison with effect studies on self-management, which
stresses the importance of conducting more economic evalua-
tion studies attached to effect studies on self-management.
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